| 发明名称 |
ORAL THERAPEUTIC COMPOUND DELIVERY SYSTEM |
| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide therapeutic formulations. <P>SOLUTION: There is provided an oral delivery system for a therapeutic compound that is a base, a salt of a base or an amphoteric compound or a salt of an amphoteric compound with pharmacological, physiological or biochemical activity or a proactive form thereof. There is provided even more particularly a swallow formulation containing a therapeutic compound that is a base, a salt of a base, an amphoteric compound or a salt of an amphoteric compound which facilitates the rapid delivery of the therapeutic compound to the circulatory system. <P>COPYRIGHT: (C)2012,JPO&INPIT |
| 申请公布号 |
JP2012162581(A) |
申请公布日期 |
2012.08.30 |
| 申请号 |
JP20120129097 |
申请日期 |
2012.06.06 |
| 申请人 |
IMAGINOT PTY LTD |
发明人 |
ROBERTS MICHAEL STEPHEN;DAVIDSON GEORGE ALEXANDER;JIANG RUOYING;ELLIOTT GERALDINE ANN;BEZANEHTAK KEIVAN;CHANDLER STEPHEN DOUGLAS;DAVEY GREG;SARKAR MANTU |
| 分类号 |
A61K45/00;A61K9/00;A61K9/20;A61K9/46;A61K31/4178;A61K31/422;A61K31/495;A61K31/519;A61K47/02;A61K47/12;A61K47/16;A61K47/18;A61K47/32;A61K47/36;A61K47/38;A61K48/00;A61P1/08;A61P15/10;A61P25/06;A61P25/20;A61P27/16;A61P29/00;A61P37/08;A61P43/00 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
